Castle Biosciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +65.7% | +127.6% | +20.8% | +50.2% | +45.7% | +60.4% | +51.1% | +3.7% | |
| – | +7.6% | +38.0% | +32.5% | +63.4% | +102.3% | +40.5% | +33.8% | +18.0% | |
| – | +98.0% | +154.8% | +18.9% | +47.8% | +34.2% | +66.4% | +55.5% | +0.5% | |
| – | +8.5% | +52.1% | +79.5% | +123.6% | +51.5% | +19.4% | -2.9% | -0.4% | |
| – | +7.9% | +81.2% | +61.3% | +80.2% | -35.0% | +17.9% | +15.2% | +19.1% | |
| – | +8.1% | +74.6% | +59.8% | +98.9% | +50.3% | +36.5% | +8.4% | +20.1% | |
| – | – | – | -189.3% | – | – | – | – | -593.8% | |
| – | +37.8% | +101.0% | -42.4% | -100.0% | +1,600.0% | -35.3% | +5,145.5% | -85.1% | |
| – | – | – | -290.7% | – | – | – | – | -236.9% | |
| – | -11.6% | +736.6% | +16.7% | -10,481.0% | – | – | +3,186.1% | -261.4% | |
| – | – | – | -294.9% | – | – | – | – | -232.4% | |
| – | – | – | -169.0% | – | – | – | – | -70.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.